Back to Search
Start Over
790MO Phase I study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel).
- Source :
-
Annals of Oncology . 2022 Supplement 7, Vol. 33, pS905-S905. 1p. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159077707
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.916